The long-term objective of the proposed research is to understand how the activation of a resident non-parenchymal liver cell, the stellate cell (previously known as lipocyte), is regulated in hepatic fibrosis and cirrhosis. Studies during the recent funding period have led to the cloning and characterization of a novel cDNA termed 'Zf9', its definition as an immediate-early gene induced during stellate cell activation in vivo, and the demonstration of its ability to specifically transactivate key genes regulating fibrogenesis. Zf9 is a member of an enlarging family of """"""""Kruppel-like"""""""" zinc finger transcription factors, which have significant roles in vasculogenesis, erythropoiesis, and lymphopoiesis. Development expression of Zf9 mRNA is tightly restricted to gut, liver and developing mesenchyme suggesting possible key roles in gastrointestinal and hepatic biology. The Hypotheses are: 1) Zf9 is a key regulator of stellate cell activation; 2) Mice lacking Zf9 will have altered gastrointestinal and hepatic morphogenesis, and Zf9 -/- stellate cells will have reduced capacity to activate 3) Targeted overexpression of Zf9 in stellate cells in vivo will enhance their activation.
The Specific Aims to test these hypotheses are: 1) To identify biologic and molecular effects of overexpressing Zf9 in cultured stellate cells. 2) To evaluate the consequences of knocking out Zf9 on embryonic development, and on hepatic injury and fibrosis in Zf9 -/- mice. 3) To examine the effects of targeted overexpression of Zf9 in stellate cells in transgenic mice driven by a stably active promoter (desmin) or one induced during stellate cell activation (alpha sm. muscle actin). The experiments are a direct extension of previously funded studies exploring the role of Zf9 in stellate cell activation, and are immediately relevant to the pathogenesis of cirrhosis in patients with chronic liver injury and fibrosis. The findings could lead to new treatments for this debilitating and incurable condition.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK037340-14
Application #
2907030
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Doo, Edward
Project Start
1987-01-01
Project End
2004-06-30
Budget Start
1999-09-01
Budget End
2000-06-30
Support Year
14
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
114400633
City
New York
State
NY
Country
United States
Zip Code
10029
Gallardo-Vara, Eunate; Blanco, Francisco J; Roqué, Mercè et al. (2016) Transcription factor KLF6 upregulates expression of metalloprotease MMP14 and subsequent release of soluble endoglin during vascular injury. Angiogenesis 19:155-71
Sawaki, Daigo; Hou, Lianguo; Tomida, Shota et al. (2015) Modulation of cardiac fibrosis by Krüppel-like factor 6 through transcriptional control of thrombospondin 4 in cardiomyocytes. Cardiovasc Res 107:420-30
Son, Bo-Kyung; Sawaki, Daigo; Tomida, Shota et al. (2015) Granulocyte macrophage colony-stimulating factor is required for aortic dissection/intramural haematoma. Nat Commun 6:6994
Layden, Jennifer E; Tayo, Bamidele O; Cotler, Scott J et al. (2014) Association of genetic variants with rapid fibrosis: progression after liver transplantation for hepatitis C. Transplantation 97:1072-8
Lee, Jung Min; Yang, Jing; Newell, Pippa et al. (2014) ?-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation. Cancer Lett 343:90-7
Tsedensodnom, Orkhontuya; Vacaru, Ana M; Howarth, Deanna L et al. (2013) Ethanol metabolism and oxidative stress are required for unfolded protein response activation and steatosis in zebrafish with alcoholic liver disease. Dis Model Mech 6:1213-26
Bechmann, Lars P; Vetter, Diana; Ishida, Junichi et al. (2013) Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis. J Hepatol 58:1000-6
Hoshida, Yujin; Villanueva, Augusto; Sangiovanni, Angelo et al. (2013) Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology 144:1024-30
Garrido-Martín, Eva M; Blanco, Francisco J; Roquè, Mercé et al. (2013) Vascular injury triggers Krüppel-like factor 6 mobilization and cooperation with specificity protein 1 to promote endothelial activation through upregulation of the activin receptor-like kinase 1 gene. Circ Res 112:113-27
Ghiassi-Nejad, Zahra; Hernandez-Gea, Virginia; Woodrell, Christopher et al. (2013) Reduced hepatic stellate cell expression of Kruppel-like factor 6 tumor suppressor isoforms amplifies fibrosis during acute and chronic rodent liver injury. Hepatology 57:786-96

Showing the most recent 10 out of 106 publications